Todd Doyle
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Vortioxetine Monotherapy for Major Depressive Disorder in Type 2 Diabetes (NCT03580967) | Todd Doyle | 2019-07-01 |
Track Todd Doyle automatically
Every clearance here is in the API, with alerts when new ones post.